Bringing the fundamentals into focus…
Back to Ascentage Pharma Group Internat
How Ascentage Pharma Group Internat stacks up
AAPG · against 411 other Healthcare companies of similar size
Growth
29/ 100
Below the middle of the pack.
Ranked #274 of 412 · scores higher than 33% of peers
Bars: peers in each 10-point band of the growth score58 peers with a growth score of 20–29, including AAPG · Click a bar to see the companies
Why growth scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 95% of peers. Revenue growth: -41.5% vs peer median 6.1%
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 91% of peers. 3-year revenue growth: 39.9% vs peer median 5.8%
Metric by metric
Position: dot = AAPG, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AAPG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 417 reported | -41.5% | 5.3% | 5% | 33% | |
| Earnings per share growthHigher is better · 227 reported | Not reported | 8.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 404 reported | 39.9% | 6.0% | 90% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around AAPG| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 272 | 163.7B INR (≈$2.0B) | 30 | 47 | |
| 272 | 1.6B USD | 30 | 29 | |
| 274 | 7.1B CNY (≈$994M) | 29 | 54 | |
| 274 | 6.0B CNY (≈$840M) | 29 | 45 | |
| 274 | 1.3B USD | 29 | 15 | |
| 274 | 1.7B USD | 29 | 30 | |
| 274 | 996M EUR (≈$1.1B) | 29 | 66 | |
| 279 | 15.1B CNY (≈$2.1B) | 28 | 60 | |
| 279 | 7.7B CNY (≈$1.1B) | 28 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score